The Enterprise Value as of November 2025 (TTM) for Ibere Pharmaceuticals (IBER) is 175.15M

According to Ibere Pharmaceuticals’s latest financial reports and current stock price. The company's current Enterprise Value is 175.15M. This represents a change of 7.20% compared to the average of 163.38M of the last 4 quarters.

Ibere Pharmaceuticals (IBER) Historical Enterprise Value (quarterly & annually)

How has IBER Enterprise Value performed in the past?

The mean historical Enterprise Value of Ibere Pharmaceuticals over the last ten years is 55.63M. The current 175.15M Enterprise Value has changed 31.39% with respect to the historical average. Over the past ten years (40 quarters), IBER's Enterprise Value was at its highest in in the September 2022 quarter at 171.10M. The Enterprise Value was at its lowest in in the June 2021 quarter at 32.51M.

Ibere Pharmaceuticals (IBER) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ibere Pharmaceuticals Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ibere Pharmaceuticals (IBER) Average Enterprise Value

How has IBER Enterprise Value performed in the past?

The current Enterprise Value of Ibere Pharmaceuticals (IBER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ibere Pharmaceuticals (IBER) Enterprise Value vs. Peers

How is IBER’s Enterprise Value compared to its peers?

Ibere Pharmaceuticals’s Enterprise Value is less than Parabellum Acquisition Corp. (177.68M), greater than Enphys Acquisition Corp. (164.20M), less than Slam Corp. (261.27M), less than Bridgetown Holdings Limited (0), less than Tristar Acquisition I Corp. (189.20M), greater than Learn CW Investment Corporation (166.33M), less than Vector Acquisition Corporation (5.18B), less than AP Acquisition Corp. (181.58M), less than Fusion Acquisition Corp. II (0),

Build a custom stock screener for Ibere Pharmaceuticals (IBER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ibere Pharmaceuticals using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ibere Pharmaceuticals (IBER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ibere Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.